Hospital economic impact from hemostatic matrix usage in cardiac surgery

References

• Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940-7
   PubMed Web of Science ®Google Scholar
• Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-52
   PubMed Web of Science ®Google Scholar
• Oz MC, Cosgrove DM 3rd, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg 2000;69:1376-82
   PubMed Web of Science ®Google Scholar
• Rady MY, Ryan T, Starr NJ. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit Care Med 1998;26:225-35
   PubMed Web of Science ®Google Scholar
• Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 2011;11:135
   PubMed Web of Science ®Google Scholar
• Moulton MJ, Creswell LL, Mackey ME, et al. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 1996;111:1037-46
   PubMed Web of Science ®Google Scholar
• Renkens KL Jr., Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976) 2001;26:1645-50
   PubMed Web of Science ®Google Scholar
• Meijer DW. Hemostats, adhesives, and sealants in endoscopic surgery. J Laparoendosc Adv Surg Tech A 2002;12:393-4
   Google Scholar
• Weaver FA, Hood DB, Zatina M, et al. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 2002;16:286-93
   PubMed Web of Science ®Google Scholar
• Nasso G, Piancone F, Bonifazi R, et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 2009;88:1520-6
   PubMed Web of Science ®Google Scholar
• California OSHPD. California Public Patient Discharge Data. Sacramento, CA: Office of Statewide Health Planning and Development, State of California, 2010. Available at: http://www.oshpd.ca.gov/HID/Products/PatDischargeData/PublicDataSet/index.html. Last accessed December 2012
   Google Scholar
• Florida AHCA. Florida 2010 Hospital Patient Discharge Data. Tallahassee, FL: Agency for Health Care Administration, State of Florida, 2010. Available at: http://www.floridahealthfinder.gov/Researchers/OrderData/orderdata.aspx. Last accessed December 2012
   Google Scholar
• Massachusetts CHIA. Massachusetts Hospital Inpatient Discharge Database. Boston, MA: Center for Health Information and Analysis (CHIA), Commonwealth of Massachusetts, 2010. Available at: http://www.mass.gov/chia/researcher/hcf-data-resources/case-mix/information-about-casemix-data.html. Last accessed December 2012
   Google Scholar
• Maryland HSCRC. Maryland Inpatient Discharge Research Data File. Baltimore, MD: Health Services Cost Review Commission (HSCRC), State of Maryland, 2010. Available at: http://www.hscrc.state.md.us/caseMixData_requests.cfm. Last accessed December 2012
   Google Scholar
• HCUP. New Jersey State Inpatient Database. Rockville, MD: Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality (AHRQ), 2010. Available at: http://www.hcup-us.ahrq.gov/sidoverview.jsp. Last accessed December 2012
   Google Scholar
• Washington CHARS. Washington Public Hospital Inpatient Discharge Data File. Olympia, WA: Comprehensive Hospital Abstract Reporting System (CHARS), Washington State Department of Health, 2010. Available at: http://www.doh.wa.gov/DataandStatisticalReports/HealthcareinWashington/HospitalandPatientData/HospitalDischargeDataCHARS.aspx. Last accessed December 2012
   Google Scholar
• Chatterjee A, Payette MJ, Demas CP, et al. Opportunity cost: a systematic application to surgery. Surgery 2009;146:18-22
   PubMed Web of Science ®Google Scholar
• Boucher BA, Hannon TJ. Blood management: a primer for clinicians. Pharmacotherapy 2007;27:1394-411
   PubMed Web of Science ®Google Scholar
• CMS. Fiscal Year 2012 Wage Index Home Page: Wage index factors. Baltimore, MD: Centers for Medicare and Medicaid Services, 2012. Available at: http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Wage-Index-Files-Items/CMS1239640.html. Last accessed December 2012
   Google Scholar
• Jameson M, Gross CW, Kountakis SE. FloSeal use in endoscopic sinus surgery: effect on postoperative bleeding and synechiae formation. Am J Otolaryngol 2006;27:86-90
   PubMed Web of Science ®Google Scholar
• Raga F, Sanz-Cortes M, Bonilla F, et al. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. Fertil Steril 2009;92:356-60
   PubMed Web of Science ®Google Scholar
• Testini M, Marzaioli R, Lissidini G, et al. The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study. Langenbecks Arch Surg 2009;394:837-42
   PubMed Web of Science ®Google Scholar
• Krishnan S, Conner TM, Leslie R, et al. Choice of hemostatic agent and hospital length of stay in cardiovascular surgery. Semin Cardiothorac Vasc Anesth 2009;13:225-30
   Google Scholar